FCGR2A and FCGR3A polymorphisms in classical hodgkin lymphoma by epstein-barr virus status

Leukemia and Lymphoma

Volumn 54, Issue 11, 2013, Pages 2571-2573

  Ghesquières, Hervé ^a,b   Dogan, Ahmet ^b   Link, Brian K ^c   Maurer, Matthew J ^b   Cunningham, Julie M ^b   Novak, Anne J ^b   Larrabee, Beth R ^b   Slager, Susan L ^b   Allmer, Cristine ^b   Habermann, Thomas M ^b   Ansell, Stephen M ^b   Cerhan, James R ^b  

^a UNIVERSITÉ LYON 1   (France)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2; FC RECEPTOR IIA; HISTIDINE; IMMUNOGLOBULIN G ANTIBODY; LATENT MEMBRANE PROTEIN 1; MESSENGER RNA; VIRUS CAPSID ANTIGEN;

ADULT; AGED; AMINO ACID SUBSTITUTION; BACTERIAL GENE; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; EPSTEIN BARR VIRUS INFECTION; EVENT FREE SURVIVAL; FCGR2A GENE; FCGR3A GENE; FEMALE; GENE; GENE FREQUENCY; GENOTYPE; HUMAN; HUMORAL IMMUNITY; LETTER; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS DETECTION;

FEMALE; GENE EXPRESSION; HUMANS; LYMPHOMA, B-CELL; MALE; POLYMORPHISM, GENETIC; RECEPTORS, IGG; VIRAL MATRIX PROTEINS;

EID: 84885642509     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.796048     Document Type: Letter

References (14)

1. Diamantopoulos PT, Kalotychou Polonyfi K, et al. Correlation ofFc-yR11A polymorphismswith latent Epstein-Barrvirus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas. Leuk Lymphoma 2013 Jan 23.
2. Bruhns P, lannascoli B, England P, et al. Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood 2009;1 13:3716-3725.
3. Thompson CA, Maurer MJ, Cerhan JR, et al. Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma. Am J Hematol 2011;86:998-1000.
4. Kuppers R. The biology of Hodgkin?s lymphoma. Nat Rev Cancer 2009;9:15-27.
5. McAulay KA, Higgins CD, Macsween KF, et al. HLA class 1 polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection. J Clin Invest 2007; 117:3042-3048.
6. Henle W, Henle G, Andersson J, et al. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proc Natl Acad Sci USA 1987;84:570-574.
7. Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin?s lymphoma after infectious mononucleosis. N Engl J Med 2003;349:1324-1332.
8. Levin LI, Chang ET, Ambinder RF, et al. Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma. Blood 2012; 120:3750-3755.
9. Hohaus 5, Santangelo R, Giachelia M, et al. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Clin Cancer Res 2011;17:2885-2892.
10. Van Sorge NM, Van Der Pol WL, Van de Winkel JG. FcgammaR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003;61:189-202.
11. Forthal DN, Landucci G, Bream J, et al. FcgammaRlla genotype predicts progression of HIV infection. J Immunol 2007; 179:7916-7923.
12. Forthal DN, Moog C. Fc receptor-mediated antiviral antibodies. Curr Opin HIV AIDS 2009;4:388-393.
13. Zheng D, Wan J, Cho YG, et al. Comparison of humoral immune responses to Epstein-Barr virus and Kaposi?s sarcoma-associated herpesvirus using a viral proteome microarray. J Infect Dis 2011;204:1683-1691.
14. Kanakry JA, Li H, Gellert LL, et al. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: Correlative analysis from a large North American co-operative group trial. Blood 2013 Feb 5.